medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2002, Number 3

<< Back Next >>

Alerg Asma Inmunol Pediatr 2002; 11 (3)

Therapeutic vaccines for allergic diseases

Ortega-Martell JA, Huerta HRE, Huerta LJ

Language: Spanish
References: 19
Page: 106-110
PDF size: 222.94 Kb.


ABSTRACT

For decades, allergen immunotherapy was practiced to the general satisfaction of allergist. The technique of allergen immunotherapy was introduced by Leonard Noon in 1911. Noon proposed that patients suffering from hay fever were sensitive to a toxin contained in grass pullen that they would benefit by induction of active immunity to this toxin produced by inoculations of active immunity to this toxin produced by moculations of a grass pollen extract. The clinical effectiveness of adequate doses in both allergic rhinitis and bronchial asthma has been repeatedly confirmed. Recent studies have revealed a broad antiinflammatory immune response and have also confirmed a persisting beneficial effect after an adequate course of allergen immunotherapy is discontinued.


REFERENCES

  1. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases: a WHO position paper. J Allergy Clin Immunol 1998; 102: 558-62.

  2. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 1: 1572-3.

  3. Norman PS. Immunotherapy: past and present. J Allergy Clin Immunol 1998; 102: 1-10.

  4. The use of standardized allergen extracts. Position statement. American Academy of Allergy, Asthma & Immunology (AAAAI). J Allergy Clin Immunol 1997: 99: 583-6.

  5. Bousquet J, Van Cauwenberge P, Khaltaev N et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Workshop Report. Journal of Allergy and Clinical Immunology, Supplemental Issue, December 2001.

  6. Durham SR, Till SJ. Immunologic change associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102: 157-64.

  7. Frew AJ. Injection Immunotherapy. British Society for Allergy and Clinical Immunology Working Party. BMJ 1993; 307: 919-23.

  8. Casanovas M, Guerra F, Moreno C, Miguel R. Double-blind placebo-controlled clinical trial of preseasonal treatment with allergenic extracts of Olea europea pollen administered sublingually. J Investig Allergol Clin Immunol 1994; 4: 305-14.

  9. Giovane AL, Bardare M, Passalacqua G et al. A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in pediatric patients. Clin Exp Allergy 1994; 24: 53-9.

  10. Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind placebo-controlled trial of a standardized five-grass pollen extract in rhinitis. Allergy 1998; 53: 493-8.

  11. Andri L, Senna G, Betteli C. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study. J Allergy Clin Immunol 1996; 97: 34-41.

  12. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151: 969-74.

  13. Bousquet J, Michel F. Specific immunotherapy in allergic rhinitis and asthma. In: Busse W, Holgate S editors. Asthma and Rhinitis. Oxford: Blackwell Scientific 1995: 1309-24.

  14. International Consensus Report on Diagnosis and Management of Rhinitis. Allergy 1994; 49 Suppl 19: 1-33.

  15. Durham S, Varney V, Gaga M, Frew A, Jacobson M, Kay A. Grass pollen immunotherapy remains effective 3 years after discontinuation: a double-blind, placebo-controlled withdrawal study. Clin Exp Allergy 1998; 28: 120-8.

  16. Des Roches A, Paradis L, Ménardo JL, Bouges S, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99: 450-3.

  17. Jacobsen L, Dreborg S, Moller C et al. Immunotherapy as a preventive treatment. J Allergy Clin Immunol 1996: 97: 232.

  18. Fell WR, Mabry RL, Mabry CS. Quality of life analysis of patients undergoing immunotherapy for allergic rhinitis. Ear Nose Throat J 1997; 76: 528-36.

  19. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001; 108: S45-53.




2020     |     www.medigraphic.com